Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.nmni.2020.100672

http://scihub22266oqcxt.onion/10.1016/j.nmni.2020.100672
suck pdf from google scholar
32322400!7171182!32322400
unlimited free pdf from europmc32322400    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32322400 :   free
PDF vom PMID32322400

suck abstract from ncbi

pmid32322400
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view #MMPMID32322400
  • Abduljalil JM; Abduljalil BM
  • New Microbes New Infect 2020[May]; 35 (ä): 100672 PMID32322400show ga
  • Since the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, the number of globally confirmed cases according to World Health Organization statistics reached 292 124 in 189 countries by 22 March 2020. The number of deaths reached 12 784, with estimated case-fatality rates ranging from 0.5% to 5.7%. Children population seems to be the least affected by the disease, while the highest rate of death is among the elderly and people with comorbidities. Most infected individuals are asymptomatic or only exhibit mild symptoms. After the incubation period, the most common symptoms are fever, cough and fatigue. Asymptomatic carrier state is of paramount importance because of carriers' ability to spread the infection and to shed the virus into the air and surroundings. Although much is still unknown about SARS-CoV-2, the scientific research is moving at an unprecedented pace towards understanding the nature, effective control, prevention and treatment of SARS-CoV-2. Various reports have suggested an in vivo evolution of the virus, which may explain the rapid spread and changing epidemiology of SARS-CoV-2, but further evidence is needed. Unfortunately, no effective treatment or therapeutic drug is available for the disease; only supportive treatment and classical intervention measures are available for confronting the SARS-CoV-2 pandemic.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    100672 ä.35 2020